Corrective Phases R...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$3.17 -0.21 | -6.21%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.38 |
| 52 Week High | 4.54 |
| 52 Week Low | 0.77 |
| Avg. Daily Vol. (Mil) | 0.23 |
| Beta (3 year) | 2.33 |
| Share Related Items | |
| Mkt Cap (Mil) | 100.15 |
| Shares Out (Mil) | 29.63 |
| Float (Mil) | 20.35 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 16.10 |
| Price/Sales | 3.03 |
| Price/Book | 4.03 |
| Price/Cash Flow | 13.60 |
| Per Share Data | |
| Earnings | 0.21 |
| Sales | 1.12 |
| Book Value | 0.84 |
| Cash Flow | 0.25 |
| Business Summary | |
|---|---|
| BioDelivery Sciences International, Inc., is a specialty pharmaceutical company that is utilizing licensed and owned proprietary drug delivery technologies to develop and commercialize new formulations of proven therapeutics. | |
| General Information | |
| 801 Corporate Center Drive
Suite 210 Raleigh, NC 27607 |
|
| www.bdsi.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 17 | |
| CEO: Dr. Mark A. Sirgo,Pharm. | |
| Short Interest | |
| Current Month (Mil) | 1.05 |
| Previous Month (Mil) | 0.84 |
| Short Interest Ratio (Days) | 3.50 |
| Management Effectiveness | |
| Return on Equity | 24.10 |
| Return on Assets | 12.90 |
| Return on Investments | 24.10 |
| Profitability | |
| Gross Margin | 96.10 |
| EBIT Margin | 18.10 |
| Profit Margin | 18.10 |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
- UserSmall Cap Bargains to follo...
- UserPROS
- UserCloud66 - IRA
Latest BDSI Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am - 10 Stocks Under $5 Outperforming in 2012 01.31.12 | 05:01 am
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 04.01.11 | 06:04 pm
- IPO Watch: 2011 02.16.11 | 01:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- Stock Offerings: MGIC Investment 04.20.10 | 11:04 am
Press Releases for BDSI
- BioDelivery Sciences To Present At The Jefferies 2012 Global Healthcare Conference - PR Newswire 05.31.12 | 07:05 am
- BioDelivery Sciences Receives $2.5 Million Milestone From Meda For BREAKYL In E.U. - PR Newswire 05.21.12 | 07:05 am
- BioDelivery Sciences Awarded Patent Resulting In $15 Million Milestone Payment - PR Newswire 04.17.12 | 07:04 am
- BioDelivery Sciences To Present At The Future Leaders In The Biotech Industry Conference - PR Newswire 04.16.12 | 08:04 am
- BioDelivery Sciences To Host Opioid Dependence Investor Event And Webcast On April 11, 2012 - PR Newswire 04.05.12 | 08:04 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Federal Court Grants Request By BioDelivery Sciences For Stay Of MonoSol Litigation - PR Newswire 03.14.12 | 07:03 am
- ONSOLIS Relaunch Postponed Pending Product Modification - PR Newswire 03.12.12 | 07:03 am
- US Patent Office Rejection Of All Claims In Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position - PR Newswire 03.06.12 | 09:03 am
- BioDelivery Sciences To Present At Cowen And ROTH Conferences - PR Newswire 03.05.12 | 07:03 am
Partner Headlines for BDSI
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- Legal Developments Bode Well For BioDelivery Sciences - Seeking Alpha 03.15.12 | 08:03 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Options Brief: BioDelivery Sciences International (BDSI) - Benzinga 12.28.10 | 09:12 am
- BioDelivery Sciences: Signs of Life - Seeking Alpha 09.10.10 | 03:09 pm
- BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug - Fox Business 09.02.10 | 05:09 pm
